Comment on

• T cell depletion by exposure to Campath-1G in vitro prevents graft-versus-host disease.

  Jacobs P, Wood L, Fullard L, Waldmann H, Hale G. Jacobs P, et al. Bone Marrow Transplant. 1994 Jun;13(6):763-9. Bone Marrow Transplant. 1994. PMID: 7920312 Clinical Trial.
• Control of graft-versus-host disease and graft rejection by T cell depletion of donor and recipient with Campath-1 antibodies. Results of matched sibling transplants for malignant diseases.

  Hale G, Waldmann H. Hale G, et al. Bone Marrow Transplant. 1994 May;13(5):597-611. Bone Marrow Transplant. 1994. PMID: 8054913